Efficacy of Epigenetic Therapy with Intensive Chemotherapy in the Treatment of Childhood Acute Myeloid Leukemias

被引：0
|
作者：
Popa, A. [1 ]
Nemirovchenko, V. [1 ]
Tiganva, O. [2 ]
Kurdyukov, B. [1 ]
Mentkevich, G. [1 ]
机构：
[1] NN Blokhin Russian Canc Res Ctr, Oncol & Hematol Res Inst, Dept Hematol Oncol Pediat, Moscow, Russia
[2] Morozovskaya Childrens Clin Hosp, Moscow, Russia
来源：
ANNALS OF HEMATOLOGY | 2019年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
78
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [41] Prediction of survival with intensive chemotherapy in acute myeloid leukemia
    Sasaki, Koji
    Ravandi, Farhad
    Kadia, Tapan
    DiNardo, Courtney
    Borthakur, Gautam
    Short, Nicholas
    Jain, Nitin
    Daver, Naval
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Khoury, Joseph
    Konoplev, Sergej
    Loghavi, Sanam
    Patel, Keyur
    Montalban-Bravo, Guillermo
    Masarova, Lucia
    Konopleva, Marina
    Kantarjian, Hagop
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (07) : 865 - 876
  • [42] Epigenetic treatment and beyond in acute myeloid leukemia
    Wei, Andrew
    HEMASPHERE, 2018, 2 : 19 - 22
  • [43] SINGLE-AGENT AND COMBINATION CHEMOTHERAPY WITH ETOPOSIDE IN THE ACUTE LEUKEMIAS OF CHILDHOOD
    RIVERA, G
    BOWMAN, WP
    LOOK, AT
    EVANS, WE
    KALWINSKY, D
    DAHL, GV
    CANCER TREATMENT REVIEWS, 1982, 9 : 53 - 57
  • [44] THE USE OF AZACITIDINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA UNFIT FOR INTENSIVE TREATMENT OR RESISTANT TO CHEMOTHERAPY
    Alpoim, M.
    Pinto, R.
    Gomes, P.
    Amorim, M.
    Carneiro, A.
    Principe, F.
    Guimaraes, J.
    HAEMATOLOGICA, 2013, 98 : 533 - 534
  • [45] Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia
    Newcombe, Ashley A.
    Gibson, Brenda E. S.
    Keeshan, Karen
    EXPERIMENTAL HEMATOLOGY, 2018, 63 : 1 - 11
  • [46] Treatment of childhood acute myeloid leukaemia
    Taub, JW
    Ravindranath, Y
    BAILLIERES CLINICAL HAEMATOLOGY, 1996, 9 (01): : 129 - 146
  • [47] Treatment of childhood acute myeloid leukemia
    ter Bals, Edske
    Kaspers, Gertjan J. L.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (05) : 917 - 929
  • [48] Expression, role and epigenetic regulation of the short form of Ron in acute myeloid leukemias (AML)
    Fialin, C.
    Vergez, F.
    Reutenauer, S.
    Mansat-De Mas, V
    Demur, C.
    Delabesse, F.
    Payrastre, B.
    Manenti, S.
    Roche, S.
    Recher, C.
    BULLETIN DU CANCER, 2010, 97 : S23 - S23
  • [49] G-CSF IN THE BIOLOGY AND TREATMENT OF ACUTE MYELOID LEUKEMIAS
    VISANI, G
    MANFROI, S
    LEUKEMIA & LYMPHOMA, 1995, 18 (5-6) : 423 - 428
  • [50] Epigenetic therapy with 5-azacitidine in a treatment schedule of five days every 4 weeks induces hematologic responses in patients with acute myeloid leukemia refractory to or not eligible for intensive chemotherapy
    Al-Ali, H. K.
    Schwind, S.
    Krahl, R.
    Becker, C.
    Leiblein, S.
    Mueller, C.
    Niederwieser, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 7 - 7
12345